ALX Oncology Holdings Inc. Common Stock (ALXO) is a publicly traded Healthcare sector company. As of July 28, 2026, ALXO trades at $1.99 with a market cap of $271.82M and a P/E ratio of -1.05. ALXO moved -1.73% today. Year to date, ALXO is +78.76%; over the trailing twelve months it is +283.88%. Its 52-week range spans $0.40 to $2.66. Analyst consensus is strong buy with an average price target of $4.67. Rallies surfaces ALXO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ALXO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.99 |
| Market Cap | $271.82M |
| P/E Ratio | -1.05 |
| EPS | $-1.90 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.66 |
| 52-Week Low | $0.40 |
| Volume | 281.04K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-101.69M |
| Gross Margin | 0.00% |
4 analysts cover ALXO: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.67.